# EDGAR Filing Document

**Accession Number:** 0001513525
**File Stem:** 0001213900-25-053826
**Filing Date:** 2025-6
**Character Count:** 2442
**Document Hash:** cf47a47c7feae02cfa14248238f69bd6
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-053826.hdr.sgml**: 20250822

**ACCESSION NUMBER**: 0001213900-25-053826

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250612

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ADIAL PHARMACEUTICALS, INC.
- **CENTRAL INDEX KEY:** 0001513525
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 800667150
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 1180 SEMINOLE TRAIL
- **STREET 2:** SUITE 495
- **CITY:** CHARLOTTESVILLE
- **STATE:** VA
- **ZIP:** 22901
- **BUSINESS PHONE:** 434-422-9800

**MAIL ADDRESS:**
- **STREET 1:** 1180 SEMINOLE TRAIL
- **STREET 2:** SUITE 495
- **CITY:** CHARLOTTESVILLE
- **STATE:** VA
- **ZIP:** 22901

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ADial Pharmaceuticals, L.L.C.
- **DATE OF NAME CHANGE:** 20170515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Adial Pharmaceuticals, L.L.C.
- **DATE OF NAME CHANGE:** 20110218

![](image_001.jpg)

June 12, 2025

 ****

***<u>VIA EDGAR</u>***

United States Securities

and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Doris Stacy Gama

---

| | |
|:---|:---|
| **Re:** | **Adial Pharmaceuticals, Inc.** |
|  | **Registration Statement on Form S-1** |
|  | **Filed June 6, 2025**<br> **File No: 333-287826** |

---

Dear Ms. Gama:

Reference is made to our letter, filed as correspondence via EDGAR on June 6, 2025, requesting acceleration of effectiveness of the above-referenced Registration Statement for **Tuesday, June 10, 2025** at 9:00 a.m. Eastern Time, which was amended via telephone and email to **Wednesday**, **June 12, 2025** at 5:00 p.m.

We are no longer requesting that such Registration Statement be declared effective at the time mentioned above, and we hereby formally withdraw our request for acceleration of the above referenced effective date.

---

| | | |
|:---|:---|:---|
| Very truly yours, | Very truly yours, | Very truly yours, |
| ADIAL PHARMACEUITCALS, INC. | ADIAL PHARMACEUITCALS, INC. | ADIAL PHARMACEUITCALS, INC. |
| By: | /s/ Cary Claiborne | /s/ Cary Claiborne |
|  | Name: | Cary Claiborne |
|  | Title: | Chief Executive Officer |

---

cc: Leslie Marlow, Blank Rome LLP